Bristol-Myers Squibb (BMY) News Today $58.22 +0.34 (+0.59%) (As of 11/21/2024 ET) Add Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. increased its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,030,403 shares of the biopharmaceuNovember 21 at 9:58 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by Banco Santander S.A.Banco Santander S.A. raised its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 475,898 shares of the biopharmaceutical company's stock after acqNovember 21 at 9:46 AM | marketbeat.comIntegrated Investment Consultants LLC Acquires New Position in Bristol-Myers Squibb (NYSE:BMY)Integrated Investment Consultants LLC bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 338,118 shares of the biopharmaceutNovember 21 at 8:25 AM | marketbeat.comJohn G Ullman & Associates Inc. Decreases Stake in Bristol-Myers Squibb (NYSE:BMY)John G Ullman & Associates Inc. decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 30.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 158,350 shares of the biopharmaceutical companyNovember 21 at 8:04 AM | marketbeat.comTrustmark National Bank Trust Department Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY)Trustmark National Bank Trust Department reduced its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 33.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 38,370 shares of the biopharmaceutical company's stock after selling 19,221 shares during theNovember 21 at 7:56 AM | marketbeat.comCypress Capital Group Sells 24,205 Shares of Bristol-Myers Squibb (NYSE:BMY)Cypress Capital Group trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 24.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 74,876 shares of the biopharmaceNovember 21 at 7:25 AM | marketbeat.comPrimecap Management Co. CA Has $1.21 Billion Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Primecap Management Co. CA decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 0.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 23,369,570 shares of the biopharmaceuticaNovember 21 at 7:15 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Intech Investment Management LLCIntech Investment Management LLC trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 19.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 389,510 shares of the biopharmaceutical company's stock after selNovember 21 at 7:02 AM | marketbeat.comBristol-Myers Squibb Q3 Earnings TranscriptNovember 21 at 7:01 AM | marketbeat.comCommerce Bank Sells 30,241 Shares of Bristol-Myers Squibb (NYSE:BMY)Commerce Bank lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 318,512 shares of the biopharmaceutical coNovember 21 at 5:21 AM | marketbeat.com77,494 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by B. Metzler seel. Sohn & Co. Holding AGB. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 77,494 shares of the biophaNovember 21 at 4:52 AM | marketbeat.comWant Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 StocksNovember 21 at 4:33 AM | fool.comProspera Financial Services Inc Grows Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Prospera Financial Services Inc increased its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 40.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,255 shares of the biopharmaceutical company's stock after purchNovember 21 at 4:32 AM | marketbeat.comPzena Investment Management LLC Increases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Pzena Investment Management LLC raised its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 0.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,201,746 shares of the biopharmaceutical company's stock after buying an additionaNovember 20 at 11:15 AM | marketbeat.comPortfolio Design Labs LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)Portfolio Design Labs LLC purchased a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 37,706 shares of the biopharmaceutical company's stock, valued at approximately $1,951,000.November 20 at 8:54 AM | marketbeat.comOntario Teachers Pension Plan Board Sells 86,115 Shares of Bristol-Myers Squibb (NYSE:BMY)Ontario Teachers Pension Plan Board lowered its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 61.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 54,945 shares of the biopharmaceutical company's stock after selling 86November 20 at 8:41 AM | marketbeat.comFirst Horizon Advisors Inc. Acquires 291,613 Shares of Bristol-Myers Squibb (NYSE:BMY)First Horizon Advisors Inc. raised its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 281.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 395,386 shares of the biopharmaceutical company's stocNovember 20 at 8:30 AM | marketbeat.comAdvisors Asset Management Inc. Increases Stake in Bristol-Myers Squibb (NYSE:BMY)Advisors Asset Management Inc. boosted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 30.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 212,439 shares of the biopharmaceutical company's stock after purchasing an additionalNovember 20 at 8:29 AM | marketbeat.comJennison Associates LLC Increases Position in Bristol-Myers Squibb (NYSE:BMY)Jennison Associates LLC increased its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 420.1% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,241,255 shares of the biopharmaceutical company's stock after buying anNovember 20 at 7:33 AM | marketbeat.comQ1 Earnings Forecast for BMY Issued By William BlairBristol-Myers Squibb (NYSE:BMY - Free Report) - Equities researchers at William Blair issued their Q1 2025 earnings per share estimates for shares of Bristol-Myers Squibb in a report released on Monday, November 18th. William Blair analyst M. Phipps forecasts that the biopharmaceutical company wiNovember 20 at 6:58 AM | marketbeat.comPremier Fund Managers Ltd Takes Position in Bristol-Myers Squibb (NYSE:BMY)Premier Fund Managers Ltd purchased a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 170,200 shares of the biopharmaceutical company's stock, vaNovember 20 at 6:28 AM | marketbeat.comCaprock Group LLC Purchases 15,870 Shares of Bristol-Myers Squibb (NYSE:BMY)Caprock Group LLC raised its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 35.5% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 60,637 shares of the biopharmaceutical company's stock after acquiring an additional 15,870 shares during the peNovember 20 at 5:07 AM | marketbeat.comTruist Financial Reaffirms Their Buy Rating on Bristol-Myers Squibb (BMY)November 20 at 4:33 AM | markets.businessinsider.comWhat is Zacks Research's Forecast for BMY FY2024 Earnings?November 20 at 2:43 AM | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Shares Up 1.6% - Here's What HappenedBristol-Myers Squibb (NYSE:BMY) Trading Up 1.6% - What's Next?November 19 at 4:17 PM | marketbeat.comBristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)November 19 at 4:05 PM | seekingalpha.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by PNC Financial Services Group Inc.PNC Financial Services Group Inc. cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.8% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 4,469,665 shares of the biopharmaceutical company's stock after selling 129,November 19 at 9:14 AM | marketbeat.comMeeder Asset Management Inc. Boosts Holdings in Bristol-Myers Squibb (NYSE:BMY)Meeder Asset Management Inc. raised its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 93.8% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 31,672 shares of the biopharmaceutical company's stock after buying an additional 15,329 shareNovember 19 at 7:21 AM | marketbeat.comOneAscent Financial Services LLC Purchases Shares of 8,855 Bristol-Myers Squibb (NYSE:BMY)OneAscent Financial Services LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 8,855 shares of the biopharmaceutical company's stock, vNovember 19 at 7:12 AM | marketbeat.comWells Fargo Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)November 19 at 6:21 AM | markets.businessinsider.comIs Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?November 19 at 6:21 AM | msn.comAviance Capital Partners LLC Lowers Position in Bristol-Myers Squibb (NYSE:BMY)Aviance Capital Partners LLC cut its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 63.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,413 shares of the biopharmaceutical company's stock after seNovember 19 at 6:17 AM | marketbeat.comMAI Capital Management Sells 26,254 Shares of Bristol-Myers Squibb (NYSE:BMY)MAI Capital Management reduced its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 18.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 116,686 shares of the biopharmaceutical company's stock after selling 26,254 shareNovember 19 at 5:24 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by Natixis Advisors LLCNatixis Advisors LLC raised its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 34.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 446,364 shares of the biopharmaceutical company's stock after purchasing an additionaNovember 19 at 4:45 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Given Consensus Recommendation of "Hold" by BrokeragesBristol-Myers Squibb (NYSE:BMY - Get Free Report) has been given an average rating of "Hold" by the twenty brokerages that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation, two haveNovember 19 at 1:14 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Trading Down 0.1% - Time to Sell?Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.1% - Here's WhyNovember 18 at 3:23 PM | marketbeat.comAljian Capital Management LLC Makes New Investment in Bristol-Myers Squibb (NYSE:BMY)Aljian Capital Management LLC bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 15,080 shares of the biopharmaceutical companyNovember 18 at 6:20 AM | marketbeat.comMill Creek Capital Advisors LLC Sells 9,989 Shares of Bristol-Myers Squibb (NYSE:BMY)Mill Creek Capital Advisors LLC lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 62.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,034 shares of the biopharmaceutical company's stockNovember 18 at 5:14 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Earns Peer Perform Rating from Analysts at Wolfe ResearchNovember 18 at 3:45 AM | americanbankingnews.comWhat is Zacks Research's Estimate for BMY FY2024 Earnings?Bristol-Myers Squibb (NYSE:BMY - Free Report) - Stock analysts at Zacks Research raised their FY2024 earnings estimates for shares of Bristol-Myers Squibb in a report issued on Thursday, November 14th. Zacks Research analyst E. Bagri now anticipates that the biopharmaceutical company will post eaNovember 18 at 2:30 AM | marketbeat.comBristol-Myers Squibb: Buy This Bargain Before It's GoneNovember 17, 2024 | seekingalpha.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Swiss National BankSwiss National Bank grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 0.3% in the third quarter, according to its most recent filing with the SEC. The firm owned 6,016,700 shares of the biopharmaceutical company's stock after acquiring an additional 15,900 shares durinNovember 17, 2024 | marketbeat.com6 of Wall Street's Most Beloved High-Yield Stocks Are On SaleNovember 17, 2024 | 247wallst.comAlpha Family Trust Purchases 9,430 Shares of Bristol-Myers Squibb (NYSE:BMY)Alpha Family Trust lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 101.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,760 shares of the bioNovember 17, 2024 | marketbeat.comAtlanta Consulting Group Advisors LLC Makes New Investment in Bristol-Myers Squibb (NYSE:BMY)Atlanta Consulting Group Advisors LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 23,252 shares of the biopharmaceutical company's stock, valued at approximately $1November 17, 2024 | marketbeat.comMutual of America Capital Management LLC Has $13.55 Million Position in Bristol-Myers Squibb (NYSE:BMY)Mutual of America Capital Management LLC trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 3.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 261,885 shares of the biopharmaceutNovember 17, 2024 | marketbeat.comSeizert Capital Partners LLC Purchases 109,849 Shares of Bristol-Myers Squibb (NYSE:BMY)Seizert Capital Partners LLC lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 18.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 717,254 shares of the biopharmaceuticaNovember 17, 2024 | marketbeat.comKinsale Capital Group Inc. Purchases 18,163 Shares of Bristol-Myers Squibb (NYSE:BMY)Kinsale Capital Group Inc. raised its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 23.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 95,597 shares of the biopharmaceutical company'sNovember 17, 2024 | marketbeat.comMizuho Securities USA LLC Has $15.62 Million Position in Bristol-Myers Squibb (NYSE:BMY)Mizuho Securities USA LLC lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 93.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 301,844 shares of the biopharmaceutical company's stockNovember 17, 2024 | marketbeat.comMizuho Markets Americas LLC Lowers Holdings in Bristol-Myers Squibb (NYSE:BMY)Mizuho Markets Americas LLC reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 7.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,579,600 shares of the biopharmaceutical company's stock after sNovember 16, 2024 | marketbeat.com Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention. Get your FREE, no-obligation Wealth Protection Guide now BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼0.920.46▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼7627▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
